(Q37273474)

19 August 2017

1 reference

title

New challenges to medicare beneficiary access to mAbs (English)

1 reference

19 August 2017

Joshua Cohen

1

1 reference

PMC publication ID

2715185

19 August 2017

Andrew Wilson

series ordinal

2

1 reference

19 August 2017

1 January 2009

1 reference

19 August 2017

Monoclonal Antibodies

1 reference

19 August 2017

1

1 reference

19 August 2017

1

1 reference

19 August 2017

56-66

1 reference

Development trends for new cancer therapeutics and vaccines.

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Development trends for monoclonal antibody cancer therapeutics.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Variability and growth in spending for outpatient specialty pharmaceuticals.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Injectable biologic case studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Anticipating the future: how the emergence of innovative biologic agents impacts benefit design, utilization, and provider relations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Promoting medical innovation while developing sound social and business policy: a conversation with Thomas G. Roberts. Interview by Barbara J. Culliton

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

What's fueling the biotech engine?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Benefit design and specialty drug use.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Patients' views of explicit rationing: what are the implications for health service decision-making?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2715185

Biotechnology and Medicare's new technology policy: lessons from three case studies

3 September 2018

1 reference

12 December 2020

Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections

1 reference

12 December 2020

Coverage with evidence development: an examination of conceptual and policy issues

1 reference

12 December 2020

Medicare program: changes to the hospital outpatient prospective payment system and CY 2008 payment rates, the ambulatory surgical center payment system and CY 2008 payment rates, the hospital inpatient prospective payment system and FY 2008 payment

1 reference

12 December 2020

Priced out of the UK market

1 reference

12 December 2020

Off-label or off-limits?

1 reference

12 December 2020

Opening Pandora's pillbox: using modern information tools to improve drug safety

1 reference

12 December 2020

Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy

1 reference

12 December 2020

Identifiers

DOI

10.4161/MABS.1.1.7246

1 reference

19 August 2017

1 reference

PMC publication ID

2715185

19 August 2017

PubMed publication ID

20046575

1 reference

PMC publication ID

2715185